Institut Pasteur
Telecommunications · France · 201-500 Employees
View Company Info for Free
Overview
Headquarters
FranceWebsite
www.institut-pasteur.comRevenue
$38.9 MillionIndustry
About Institut Pasteur
Institut Pasteur Org Chart
Spécialiste De Laboratoire
Scientist
Stagiaire
Is Institut Pasteur your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Institut Pasteur recently announced quarterly report
Check out if Institut Pasteur is spiking on competitors!
Click to see if Institut Pasteur had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Institut Pasteur has new funding data
Congratulate Masked Content for being promoted to Masked Content at Institut Pasteur
Institut Pasteur, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Institut Pasteur has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Institut Pasteur launches new products
Recommended Actions
Find VP level buyers at Institut Pasteur
Find 2 more new buyers
Company Profile Activity
Activity Insights
Institut Pasteur is experiencing very low activity levels compared to other companies in the Telecommunications sector.
What does this means?
Institut Pasteur is drawing exceptional interest within the Telecommunications industry, suggesting notable developments or strong market momentum, learn more about Institut Pasteur.
Institut Pasteur News & Media
SpikImm, a Biotechnology Company Founded by Truffle Capital Under License from the Institut Pasteur, Announces that the Clinical Trials for SPK001, its Monoclonal Antibody Against SARS-COV-2, Have Begun
PARIS--(BUSINESS WIRE)--SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the Phase 1 clinical study, recently labeled as a "national priority" by CAPNET (
Top Telecommunications Companies
Frequently Asked Questions Regarding Institut Pasteur
Institut Pasteur is a company that operates in the Telephony & Wireless industry. It employs 250to499 people and has 25Mto50M of revenue. The company is headquartered in France.... Read More